Chemokine CXCL12 enhances proliferation in Pre-B-ALL via STAT5 activation

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 812-817

  Mowafi, Frida ^a   Cagigi, Alberto ^a   Matskova, Ludmila ^a   Björk, Olle ^b   Chiodi, Francesca ^a   Nilsson, Anna ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B lymphocytes; Chemokines; Leukaemia; STAT5

Indexed keywords

CD19 ANTIGEN; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; STAT5 PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADOLESCENT; CELL PROLIFERATION; CHEMOKINE CXCL12; CHILD; CHILD, PRESCHOOL; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; RECEPTORS, CXCR4; RECOMBINANT PROTEINS; STAT5 TRANSCRIPTION FACTOR;

EID: 40449121882     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21370     Document Type: Article

References (29)

1. Gustafsson G, Schmiegelow K, Forestier E, et al. Improving outcome through two decades in childhood ALL in the Nordic countries. The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric haematology and Oncology (NOPHO). Leukemia 2000;14:2267-2275.
2. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001;78:57-110.
3. Möhle R, Schittenheim M, Failenschmid C, et al. Functional response of leukemic blasts to stromal cell derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukemia. Br J Haematol 2000;110:563-572.
4. Durig J, Rosenthal C, Elmaagacli A, et al. Biological effects of stromal-derived factor-1a on normal and CML CD34+ haematopoetic cells. Leukemia 2000;14:1652-1660.
5. Nishii K, Katayama N, Miwa H, et al. Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: Association with the expression of bcl-2 protein. Br J Haematol 1999;105:701-710.
6. D́Apuzzo M, Rolink A, Loetscher M, et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CX CR4. Eur J Immunol 1997;27:1788-1793.
7. Bendall L, Baraz R, Juarez J, et al. Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor 1 in acute lymphoblastic leukemia. Cancer Res 2005;65:3290-3298.
8. Wang J, Park I, Groopman JE. Stromal cell-derived factor 1 stimulates tyrosine phosporylation of multiple focal adhesion proteins and induce migration of hematopoetic progenitor cells, roles of phospoinositide 3-kinase and protein kinase C. Blood 2000;95:2505-2513.
9. Soriano S, Serrano A, Hernanz- Falcon P, et al. Chemokines integrate JAK/STAT and G-protein pathways during chemotaxis and calcium flux responses. Eur J Immunol 2003;33:1328-1333.
10. Kato Y, Iwama A, Tadokoro Y, et al. Selective activation of STAT5 unveils its role in stem cell self-renwal in normal and leukemic hematopoesis. J Exp Med 2005;202:169-179.
11. Vila-Coro A, Rodriguez-Frade J, Martin De Ana A, et al. The chemokine SDF-1 triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB 1999;13:1699-1710.
12. Derdeyn CA, Costello C, Kilby JM, et al. Correlation between circulating stromal cell-derived factor-1 levels and CD4+ cell count in human immunodefiency virus type 1-infected individuals. AIDS Res Hum Retroviruses 1999;15:1063-1071.
13. Juarez J, Baraz R, Gaundar S, et al. Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia. Haematologica 2007;92:450-459.
14. Lataillade J-J, Clay D, Bourin P, et al. Stromal cell-derived factor 1 regulates primitive hematopoesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells; evidence for an autocrine/paracrine mechanism. Blood 2002;99:1117-1129.
15. Honczarenko M, Lee Y, Swierkowski M, et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem cells Express 2006;24:1030-1041.
16. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoesis and bone marrow myelopoesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638.
17. Nakayama T, Hieshima K, Izawa D, et al. Cutting edge: Profile of chemokine receptor expression on human plasma cells account for their efficient recruitment to target tissues. J Immunol 2003;170:1136-1140.
18. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999;10:463-471.
19. Sei S, ÓNeill DP, Stewart SK, et al. Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma. Cancer Res 2001;61:5028-5037.
20. Lorgeot V, Rougier F, Fixe P, et al. Spontaneous and inducible production of leukemia inhibitory factor by human bone marrow stromal cells. Cytokine 1997;9:754-758.
21. Tomita T, Takeuchi E, Toyosaki-Maeda T, et al. Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: Indication of characteristic bone marrow microenvironmet in patients with rheumatoid arthritis. Rheumatology 1999;38:854-863.
22. Li A, Zhang Q, Jiang J, et al. Co-transplantation of bone-marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice. Gene Ther 2006;13:1178-1187.
23. Honczarenko M, Douglas RS, Mathias C, et al. SDF-1 responsiveness does not correlate with CXCR4 expression levels on developing human bone marrow B cells. Blood 1999;94:2990-2998.
24. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002;109:1139-1142.
25. Scheeren FA, Naspetti M, Diehl S, et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol 2005;6:303-313.
26. Juarez J, Bradstock KF, Gottlieb DJ, et al. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia 2003;17:1294-1300.
27. Bertolini F, DellÁgnola C, Mancusa P, et al. CXCR4 neutralization, a novel therapeutical approach for non-Hodgkiń lymphoma. Cancer Res 2002;62:3106-3112.
28. Bereschenko OR, Gu W, Della-Favera R. Acetylation inactivates the transcriptional repressor Bcl-6. Nat Genet 2002;32:606-613.
29. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002;8:945-954.